ImageneBio, Inc.
IMA· Nasdaq
Released Mar 6, 2025, before the open
10-K filed Mar 6, 2025, 65 days after period end · 0000950170-25-034188
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $658.00K | $5.45M | $20.22M |
| Net Income | -$4.81M | -$19.49M |
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR
| -$14.10M |
| $2.80M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.